Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 27, Number 5—May 2021
Dispatch

Detecting Rapid Spread of SARS-CoV-2 Variants, France, January 26–February 16, 2021

Stéphanie Haim-Boukobza, Bénédicte Roquebert, Sabine Trombert-Paolantoni, Emmanuel Lecorche, Laura Verdurme, Vincent Foulongne, Christian Selinger, Yannis Michalakis, Mircea T. Sofonea1, and Samuel Alizon1Comments to Author 
Author affiliations: Cerba Laboratory, Saint Ouen L’Aumône, France (S. Haim-Boukobza, B. Roquebert, S. Trombert-Paolantoni, E. Lecorche, L. Verdurme); CHU de Montpellier, Montpellier, France (V. Foulongne); IRD, Montpellier (C. Selinger); CNRS, Montpellier (Y. Michalakis, S. Alizon); Université de Montpellier, Montpellier (M.T. Sofonea)

Main Article

Figure 1

Estimated variants frequency kinetics in study of rapid spread of severe acute respiratory syndrome coronavirus 2 spread, France, January 26–February 16, 2021. Triangles indicate the general linear model–fitted values, line indicates output of the logistic growth model estimation, and shading indicates 95% CIs. Overall estimated transmission advantage of the variants (with respect to the wild-type reproduction number) is 50 (95% CI 38%–64%) (Appendix 2). VOC, variant of concern.

Figure 1. Estimated variants frequency kinetics in study of rapid spread of severe acute respiratory syndrome coronavirus 2 spread, France, January 26–February 16, 2021. Triangles indicate the general linear model–fitted values, line indicates output of the logistic growth model estimation, and shading indicates 95% CIs. Overall estimated transmission advantage of the variants (with respect to the wild-type reproduction number) is 50 (95% CI 38%–64%) (Appendix 2). VOC, variant of concern.

Main Article

1These authors contributed equally to this article.

Page created: March 22, 2021
Page updated: April 22, 2021
Page reviewed: April 22, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external